Jazz Pharmaceuticals, Inc. (JAZZ) Financials

Key financial figures for Jazz Pharmaceuticals, Inc. (Q3 2026).

Jazz Pharmaceuticals plc reported revenue of $1.24 billion for Q3 FY2026, up 10.4% from the same period a year earlier. The company posted a net loss of $483.4 million, or -$7.48 per share. Operating margin came to -33.26%, against 5.11% a year earlier. Free cash flow for the period was $489.9 million. Across the last 5 reported quarters, quarterly revenue has risen from $1.13 billion in Q3 FY2025 to $1.24 billion in Q3 FY2026. The figures above are as filed, and the full income statement, balance sheet and cash flow history for Jazz Pharmaceuticals plc are on the SentiSense financials page.

Revenue
$1.2B
Net Income
-$483M
EPS
$-7.48
Total Assets
$12.0B
Operating Cash Flow
$506M

Recent quarters

PeriodRevenueNet IncomeEPSOperating MarginFree Cash Flow
Q3 FY2026$1.2B-$483M-$7.48-33.26%$490M
Q2 FY2026$1.2B$193M$2.7820.54%$398M
Q1 FY2026$1.1B$293M$4.4320%$389M
Q4 FY2025$1.2B$203M$3.3475.9%$297M
Q3 FY2025$1.1B$251M$4.085.11%$459M

Recent fiscal years

PeriodRevenueNet IncomeEPSOperating MarginFree Cash Flow
FY2025$4.3B-$356M-$5.845.26%$1.1B
FY2024$4.1B$560M$8.6517.61%$1.3B
FY2023$3.8B$415M$6.1015.09%$1.1B

Frequently asked questions

What was Jazz Pharmaceuticals plc's revenue last quarter?

Jazz Pharmaceuticals plc reported revenue of $1.24 billion for Q3 FY2026, up 10.4% from the same period a year earlier.

Is Jazz Pharmaceuticals plc profitable?

Not in its most recent reported period. Jazz Pharmaceuticals plc reported a net loss of $483.4 million for Q3 FY2026, a net margin of -38.89% on revenue.

How has Jazz Pharmaceuticals plc's margin trended?

Operating margin was -33.26% in Q3 FY2026, compared with 5.11% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.

How much free cash flow did Jazz Pharmaceuticals plc generate?

Jazz Pharmaceuticals plc generated free cash flow of $489.9 million in Q3 FY2026, after capital expenditure.

Full income statement, balance sheet and cash flow for Jazz Pharmaceuticals, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.